Galen profits rise as it turns attention to US with name change

GALEN HOLDINGS plans to complete its metamorphosis from an Irish pharmaceuticals group into a company focused on the US by changing its name to Warner Chilcott.

Galen, which specialises in women’s healthcare, yesterday posted a sharp rise in second quarter net profit, ahead of expectations.

Davy analyst Jack Gorman said: “To reflect its almost exclusive US bias, the company is proposing to change its name to Warner Chilcott and will change its year-end to December.”